Organigram: Strong long term buy opportunity.
Despite Organigram Holdings Inc continuous 5 month sell-off, the stock has reached a point where there are 3 strong technical factors supporting the idea that a strong bounce may emerge.
1. The price hit the 4.15 1M Support which is holding since December 2018.
2. The price has almost made contact with the 1W MA200.
3. The RSI on the 1W chart is past 30.00, a point it last traded during October 2015 when it had an aggressive rise of +600%.
Now we are not suggesting that another +600% rise will emerge (that would bring the stock at $30) but we are at a point when adding OGI to your portfolio would be beneficial over the long term. We are looking towards a 11.30 target.
** If you like our free content follow our profile (tradingview.com/u/InvestingScope) to get more daily ideas. **
Comments and likes are greatly appreciated.
1. The price hit the 4.15 1M Support which is holding since December 2018.
2. The price has almost made contact with the 1W MA200.
3. The RSI on the 1W chart is past 30.00, a point it last traded during October 2015 when it had an aggressive rise of +600%.
Now we are not suggesting that another +600% rise will emerge (that would bring the stock at $30) but we are at a point when adding OGI to your portfolio would be beneficial over the long term. We are looking towards a 11.30 target.
** If you like our free content follow our profile (tradingview.com/u/InvestingScope) to get more daily ideas. **
Comments and likes are greatly appreciated.
Telegram: t.me/investingscope
investingscope.com
Over 65% accuracy on Private Signals Channel.
Over 15% return monthly on our Account Management Plan.
Account RECOVERY services.
Free Channel: t.me/investingscopeofficial
investingscope.com
Over 65% accuracy on Private Signals Channel.
Over 15% return monthly on our Account Management Plan.
Account RECOVERY services.
Free Channel: t.me/investingscopeofficial
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.